Table 4 GO and KEGG enrichment analyses of STMN1 and functional partner genes in HCC
From: STMN1 as a novel prognostic biomarker in HCC correlating with immune infiltrates and methylation
Ontology | ID | Description | p-value |
|---|---|---|---|
BP | GO:0010389 | Regulation of G2/M transition of mitotic cell cycle | 2.93e-08 |
BP | GO:1901990 | Regulation of mitotic cell cycle phase transition | 3.39e-08 |
BP | GO:0000086 | G2/M transition of mitotic cell cycle | 9.29e-08 |
BP | GO:0007093 | Mitotic cell cycle checkpoint | 1.19e-06 |
BP | GO:1903580 | Positive regulation of ATP metabolic process | 1.77e-06 |
BP | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 3.02e-06 |
BP | GO:1901991 | Negative regulation of mitotic cell cycle phase transition | 5.99e-06 |
BP | GO:0018105 | Peptidyl-serine phosphorylation | 1.25e-05 |
CC | GO:0005874 | Microtubule | 9.43e-07 |
CC | GO:0000780 | Condensed nuclear chromosome, centromeric region | 7.48e-05 |
MF | GO:0035173 | Histone kinase activity | 8.80e-08 |
MF | GO:0005200 | Structural constituent of cytoskeleton | 2.17e-05 |
MF | GO:0004674 | Protein serine/threonine kinase activity | 6.97e-05 |
MF | GO:0004683 | Calmodulin-dependent protein kinase activity | 1.08e-04 |
KEGG | hsa04540 | Gap junction | 1.59e-06 |
KEGG | hsa04110 | Cell cycle | 2.77e-04 |
KEGG | hsa04068 | FoxO signaling pathway | 3.26e-04 |
KEGG | hsa04210 | Apoptosis | 3.64e-04 |
KEGG | hsa04145 | Phagosome | 5.05e-04 |
KEGG | hsa04530 | Tight junction | 6.89e-04 |
KEGG | hsa05130 | Pathogenic Escherichia coli infection | 0.001 |
KEGG | hsa05203 | Viral carcinogenesis | 0.001 |
KEGG | hsa05206 | MicroRNAs in cancer | 0.044 |